IA
EXEL icon

IndexIQ Advisors’s Exelixis EXEL Stock Holding History

IndexIQ Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$61K Buy
+2,712
New +$53K ﹤0.01% 1124

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IndexIQ Advisors's EXEL Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Exelixis (EXEL) in Q1 2022: 2,712 shares worth $61K. The stake represents ﹤0.01% of the portfolio and ranks #1124 among its holdings.

363 funds tracked by Wall St. Rank hold EXEL as of Q1 2022.

  • IndexIQ Advisors held 2,712 shares of Exelixis worth $61K as of Q1 2022.
  • Exelixis was a new IndexIQ Advisors position in Q1 2022.
  • Exelixis made up ﹤0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1124 holding.
  • 363 funds tracked by Wall St. Rank held Exelixis as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.